Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 162 Pages
Report ld: 5344198
Request Sample
Customized Report
The global Neonatal Phototherapy Units market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Neonatal Phototherapy Units leading manufacturers including GE Healthcare, Weyer GmbH, Delta Medical International, Natus Medical Incorporated, Medicor, Drager, Zeal Medical, MTTS, David Medical Device, BEING MEDICAL DEVICE, etc., dominate supply; the top five capture approximately % of global revenue, with GE Healthcare leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Neonatal Phototherapy Units market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Neonatal Phototherapy Units study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Neonatal Phototherapy Units: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Neonatal Phototherapy Units Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Single Surface Phototherapy Units
1.2.3 Double Surface Phototherapy Units
1.3 Market Segmentation by Application
1.3.1 Global Neonatal Phototherapy Units Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Confinement Centers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Neonatal Phototherapy Units Revenue Estimates and Forecasts 2020-2031
2.2 Global Neonatal Phototherapy Units Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Neonatal Phototherapy Units Sales Estimates and Forecasts 2020-2031
2.4 Global Neonatal Phototherapy Units Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Neonatal Phototherapy Units Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Neonatal Phototherapy Units Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Single Surface Phototherapy Units Market Size by Manufacturers
3.5.2 Double Surface Phototherapy Units Market Size by Manufacturers
3.6 Global Neonatal Phototherapy Units Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Neonatal Phototherapy Units Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Neonatal Phototherapy Units Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Neonatal Phototherapy Units Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Neonatal Phototherapy Units Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Neonatal Phototherapy Units Sales and Revenue by Type (2020-2031)
6.4 North America Neonatal Phototherapy Units Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Neonatal Phototherapy Units Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Neonatal Phototherapy Units Sales and Revenue by Type (2020-2031)
7.4 Europe Neonatal Phototherapy Units Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Neonatal Phototherapy Units Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Neonatal Phototherapy Units Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Neonatal Phototherapy Units Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Neonatal Phototherapy Units Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Neonatal Phototherapy Units Sales and Revenue by Type (2020-2031)
9.4 Central and South America Neonatal Phototherapy Units Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Neonatal Phototherapy Units Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Neonatal Phototherapy Units Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Neonatal Phototherapy Units Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Neonatal Phototherapy Units Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 GE Healthcare
11.1.1 GE Healthcare Corporation Information
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.1.4 GE Healthcare Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 GE Healthcare Neonatal Phototherapy Units Sales by Product in 2024
11.1.6 GE Healthcare Neonatal Phototherapy Units Sales by Application in 2024
11.1.7 GE Healthcare Neonatal Phototherapy Units Sales by Geographic Area in 2024
11.1.8 GE Healthcare Neonatal Phototherapy Units SWOT Analysis
11.1.9 GE Healthcare Recent Developments
11.2 Weyer GmbH
11.2.1 Weyer GmbH Corporation Information
11.2.2 Weyer GmbH Business Overview
11.2.3 Weyer GmbH Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.2.4 Weyer GmbH Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Weyer GmbH Neonatal Phototherapy Units Sales by Product in 2024
11.2.6 Weyer GmbH Neonatal Phototherapy Units Sales by Application in 2024
11.2.7 Weyer GmbH Neonatal Phototherapy Units Sales by Geographic Area in 2024
11.2.8 Weyer GmbH Neonatal Phototherapy Units SWOT Analysis
11.2.9 Weyer GmbH Recent Developments
11.3 Delta Medical International
11.3.1 Delta Medical International Corporation Information
11.3.2 Delta Medical International Business Overview
11.3.3 Delta Medical International Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.3.4 Delta Medical International Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Delta Medical International Neonatal Phototherapy Units Sales by Product in 2024
11.3.6 Delta Medical International Neonatal Phototherapy Units Sales by Application in 2024
11.3.7 Delta Medical International Neonatal Phototherapy Units Sales by Geographic Area in 2024
11.3.8 Delta Medical International Neonatal Phototherapy Units SWOT Analysis
11.3.9 Delta Medical International Recent Developments
11.4 Natus Medical Incorporated
11.4.1 Natus Medical Incorporated Corporation Information
11.4.2 Natus Medical Incorporated Business Overview
11.4.3 Natus Medical Incorporated Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.4.4 Natus Medical Incorporated Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Natus Medical Incorporated Neonatal Phototherapy Units Sales by Product in 2024
11.4.6 Natus Medical Incorporated Neonatal Phototherapy Units Sales by Application in 2024
11.4.7 Natus Medical Incorporated Neonatal Phototherapy Units Sales by Geographic Area in 2024
11.4.8 Natus Medical Incorporated Neonatal Phototherapy Units SWOT Analysis
11.4.9 Natus Medical Incorporated Recent Developments
11.5 Medicor
11.5.1 Medicor Corporation Information
11.5.2 Medicor Business Overview
11.5.3 Medicor Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.5.4 Medicor Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Medicor Neonatal Phototherapy Units Sales by Product in 2024
11.5.6 Medicor Neonatal Phototherapy Units Sales by Application in 2024
11.5.7 Medicor Neonatal Phototherapy Units Sales by Geographic Area in 2024
11.5.8 Medicor Neonatal Phototherapy Units SWOT Analysis
11.5.9 Medicor Recent Developments
11.6 Drager
11.6.1 Drager Corporation Information
11.6.2 Drager Business Overview
11.6.3 Drager Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.6.4 Drager Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Drager Recent Developments
11.7 Zeal Medical
11.7.1 Zeal Medical Corporation Information
11.7.2 Zeal Medical Business Overview
11.7.3 Zeal Medical Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.7.4 Zeal Medical Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Zeal Medical Recent Developments
11.8 MTTS
11.8.1 MTTS Corporation Information
11.8.2 MTTS Business Overview
11.8.3 MTTS Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.8.4 MTTS Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 MTTS Recent Developments
11.9 David Medical Device
11.9.1 David Medical Device Corporation Information
11.9.2 David Medical Device Business Overview
11.9.3 David Medical Device Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.9.4 David Medical Device Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 David Medical Device Recent Developments
11.10 BEING MEDICAL DEVICE
11.10.1 BEING MEDICAL DEVICE Corporation Information
11.10.2 BEING MEDICAL DEVICE Business Overview
11.10.3 BEING MEDICAL DEVICE Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.10.4 BEING MEDICAL DEVICE Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 BEING MEDICAL DEVICE Recent Developments
11.11 BIOBASE
11.11.1 BIOBASE Corporation Information
11.11.2 BIOBASE Business Overview
11.11.3 BIOBASE Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.11.4 BIOBASE Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 BIOBASE Recent Developments
11.12 Julongsanyou Technology
11.12.1 Julongsanyou Technology Corporation Information
11.12.2 Julongsanyou Technology Business Overview
11.12.3 Julongsanyou Technology Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.12.4 Julongsanyou Technology Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Julongsanyou Technology Recent Developments
11.13 Phoenix Medical Systems
11.13.1 Phoenix Medical Systems Corporation Information
11.13.2 Phoenix Medical Systems Business Overview
11.13.3 Phoenix Medical Systems Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.13.4 Phoenix Medical Systems Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Phoenix Medical Systems Recent Developments
11.14 Ibis Medical
11.14.1 Ibis Medical Corporation Information
11.14.2 Ibis Medical Business Overview
11.14.3 Ibis Medical Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.14.4 Ibis Medical Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Ibis Medical Recent Developments
11.15 Apothecaries Sundries Manufacturing
11.15.1 Apothecaries Sundries Manufacturing Corporation Information
11.15.2 Apothecaries Sundries Manufacturing Business Overview
11.15.3 Apothecaries Sundries Manufacturing Neonatal Phototherapy Units Product Models, Descriptions and Specifications
11.15.4 Apothecaries Sundries Manufacturing Neonatal Phototherapy Units Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Apothecaries Sundries Manufacturing Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Neonatal Phototherapy Units Industry Chain
12.2 Neonatal Phototherapy Units Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Neonatal Phototherapy Units Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Neonatal Phototherapy Units Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Neonatal Phototherapy Units Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Neonatal Phototherapy Units Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
The global Neonatal Phototherapy Units market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 126
USD 2900.00
(Single User License)
The global Neonatal Phototherapy Units market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 99
USD 4250.00
(Single User License)
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 129
USD 3950.00
(Single User License)
The global market for Neonatal Phototherapy Units was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 94
USD 2900.00
(Single User License)
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
Published Date: 2024-01-17
Pages: 99
USD 2900.00
(Single User License)
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 142
The global Neonatal Phototherapy Units market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 126
The global Neonatal Phototherapy Units market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 99
The global market for Neonatal Phototherapy Units was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 129
The global market for Neonatal Phototherapy Units was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 94
Jaundice (Hyperbilirubinemia) is a common condition, particularly in pre-mature babies worldwide. The skin of the newborn baby becomes jaundiced (baby’s skin and Sclerae appear yellow) which is caused by a high level of bilirubin in the blood. Bilirubin is a waste product, produced when red blood cells are broken down. It is normally broken down in the liver and removed from the body in the stool. However, an underdeveloped liver of infant cannot filter out the bilirubin as fast as it i being produced, resulting in hyperbilirubinemia (Jaundice). If untreated the levels of bilirubin may rise high enough to pass through the blood brain barrier and is deposited in the brain causing Kernicterus and brain damage. Phototherapy is a treatment with special type of light (wavelength range 420 to 480nm) which lower bilirubin level in neonatal, the process is called photo-oxidation in which light wave converts the bilirubin to water soluble non-toxic form, make it easier for baby’s liver to break down and remove the bilirubin from their blood.
Published: 2024-01-17
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now